Proteasome inhibitor associated thrombotic microangiopathy-Reference-Cited by-同舟云学术

Proteasome inhibitor associated thrombotic microangiopathy

Published:2016-07-04 Issue:9 Volume:91 Page:E348-E352
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Yui Jennifer C.¹,Van Keer Jan²,Weiss Brendan M.³,Waxman Adam J.³,Palmer Matthew B.⁴,D'Agati Vivette D.⁵,Kastritis Efstathios⁶,Dimopoulos Meletios A.⁶,Vij Ravi⁷,Bansal Dhruv⁷,Dingli David⁸,Nasr Samih H.⁹,Leung Nelson⁸¹⁰

Affiliation:

1. Department of Medicine; Mayo Clinic; Rochester Minnesota

2. Department of Cardiology; University Hospitals Leuven; Leuven Belgium

3. Division of Hematology and Oncology, Abramson Cancer Center; University of Pennsylvania; Philadelphia Pennsylvania

4. Department of Pathology and Laboratory Medicine; University of Pennsylvania; Philadelphia Pennsylvania

5. Department of Pathology and Cell Biology; Columbia University Medical Center; New York New York

6. Department of Clinical Therapeutics; National and Kapodistrian, University of Athens, School of Medicine; Athens Greece

7. Division of Hematology and Oncology; Washington University School of Medicine; St. Louis Missouri

8. Division of Hematology; Mayo Clinic; Rochester Minnesota

9. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota

10. Division of Nephrology and Hypertension; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Reference27 articles.

1. Syndromes of thrombotic microangiopathy;George;N Engl J Med,2014

2. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma registry and the bloodcenter of Wisconsin;Reese;Am J Hematol,2015

3. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes;Kojouri;Ann Intern Med,2001

4. Thrombotic thrombocytopenic purpura associated with clopidogrel;Bennett;N Engl J Med,2000

5. Cyclosporine and tacrolimus-associated thrombotic microangiopathy;Pham;Am J Kidney Dis,2000

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review;Annals of Hematology;2024-08-27

2. Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment—An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide;Blood Reviews;2024-07

4. Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura;Cureus;2024-06-23

5. Clinical features, treatment, and outcomes of patients with carfilzomib induced thrombotic microangiopathy;International Immunopharmacology;2024-06